News
News Center
2022-09-01
Jiuzhitang Maker has been selected for Beijing's "Specialized, Fine, and New" enterprise list.
Jiuzhitang Maker Named to Beijing's "Specialized, Fine, and New" Enterprise List
+
2022-08-22
On the evening of August 20, CCTV2's "Dialogue" program specially invited Academician Xiuwu Bian, an academician of the Chinese Academy of Sciences and head of the expert panel for the national key R&D project on "Stem Cells and Organ Repair," along with Researcher Baoyang Hu, Executive Director of the Beijing Institute of Stem Cell and Regenerative Medicine, to jointly discuss the future of stem cells.
+
2022-08-17
The plan proposes mobilizing the entire city to build a stem cell and regenerative medicine cluster, positioning it as a flagship highlight of Kunming's booming health industry. It also calls for exploring standardized technical and manufacturing guidelines for cell therapies, as well as clinical application protocols, while fostering pilot initiatives aimed at advancing clinical research and translational applications in cell therapy—and ultimately charting innovative pathways for the growth of this cutting-edge field.
+
2022-08-12
Explore new open-development models for stem cell, genetic diagnostics, and therapeutic technology development and application. Implement major initiatives such as tackling critical core technologies and enhancing clinical translation capabilities, accelerating the creation of a world-class industrial cluster.
+
2022-08-12
Henan Provincial Development and Reform Commission: We will continue to deepen international cooperation and support pilot reforms—particularly in areas such as cell therapy, traditional Chinese medicine, and regulatory oversight of TCM medical devices—leveraging the China (Henan) Pilot Free Trade Zone. Additionally, we will encourage medical institutions within the zone to import urgently needed, highly effective foreign-approved yet domestically unlisted pharmaceuticals and medical devices.
+
2022-08-03
The plan explicitly states: Actively seek pilot policies for biomedicine, aligning with the growing demand of precision medicine industries such as gene therapy and stem cells. Additionally, we will proactively work to introduce these pioneering initiatives—originally implemented in areas like Boao Lecheng in Hainan—into the new development zone.
+
2022-07-28
Support applying for national-level qualifications to facilitate clinical translation, promote application, and launch pilot programs for cutting-edge stem cell technologies and new products. Focus will be placed on conducting foundational research into hematopoietic stem cells, umbilical cord mesenchymal stem cells, the storage of umbilical cord mesenchymal stem cells, and pluripotent stem cells, among others.
+
2022-07-19
On July 17, according to information released by Sun Junhao's agency, the player sustained a medial collateral ligament injury in his right knee during the 10th round of the Chinese Super League. While the injury isn't considered severe, Sun will now undergo stem cell injection therapy. He is expected to return to action as early as the end of August.
+
2022-07-12
Concord Medicine: The Beauty Application Prospects of Stem Cells
The safety of clinical applications of stem cells has already been preliminarily demonstrated, and we believe that in the near future, stem cell therapies will become a part of our daily lives, safeguarding people's health!
+
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy